James E. Flynn, 10% Owner at RHYTHM PHARMACEUTICALS, INC. (RYTM), bought 177,500 shares at $17.00 ($3.0M) on 2017-10-10, disclosed to the SEC on 2017-10-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |